These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31398515)

  • 21. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up.
    Ko DY; Kim KH; Song KH
    Br J Dermatol; 2014 Jan; 170(1):165-72. PubMed ID: 24102369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence diagnosis and photodynamic therapy for Bowen's disease treatment.
    Truchuelo MT; Pérez B; Fernández-Guarino M; Moreno C; Jaén-Olasolo P
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):86-93. PubMed ID: 23331846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Huge Bowen's disease: a pitfall of topical photodynamic therapy.
    Park JY; Kim SK; Cho KH; Kim YC
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):546-8. PubMed ID: 24284109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease.
    Salim A; Leman JA; McColl JH; Chapman R; Morton CA
    Br J Dermatol; 2003 Mar; 148(3):539-43. PubMed ID: 12653747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen's disease.
    Mizutani K; Akita Y; Yanagishita T; Kimura M; Tanaka T; Kinoshita Y; Nakano A; Tamada Y; Matsumoto Y; Watanabe D
    Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):142-6. PubMed ID: 22548396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
    Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
    J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world data of 5-aminolaevulinic acid-mediated photodynamic therapy for Bowen disease: a 10-year retrospective study in patients with darker-coloured skin (2011-2021).
    Fang S; Zhang L; Wang P; Shi L; Zhang H; Liao C; Zhao Z; Zhou Z; Zhao Y; Yan G; Wu Y; Wu Y; Zheng Z; Wang R; Liu Y; Zhang G; Wang X
    Clin Exp Dermatol; 2024 Sep; 49(10):1190-1196. PubMed ID: 38641554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
    Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy.
    Stables GI; Stringer MR; Robinson DJ; Ash DV
    Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
    Kim HJ; Song KH
    J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periocular photodynamic therapy for squamous intra-epidermal carcinoma.
    Casie Chetty N; Hemmant B; Skellett AM
    J Dermatolog Treat; 2014 Dec; 25(6):516-8. PubMed ID: 24215518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical photodynamic therapy for Bowen's disease.
    Morton CA
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S11; discussion S23-5. PubMed ID: 15859302
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy.
    Morton CA; Whitehurst C; Moore JV; MacKie RM
    Br J Dermatol; 2000 Oct; 143(4):767-72. PubMed ID: 11069454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of metil aminolevulinate (MAL)-PDT in difficult-to-treat cutaneous Bowen's disease.
    Cavicchini S; Serini SM; Fiorani R; Girgenti V; Ghislanzoni M; Sala F
    Int J Dermatol; 2011 Aug; 50(8):1002-5. PubMed ID: 21781078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy.
    Valentine RM; Ibbotson SH; Brown CT; Wood K; Moseley H
    Photochem Photobiol; 2011; 87(1):242-9. PubMed ID: 21077899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of sequential therapy in digital Bowen's disease with methyl aminolevulinate photodynamic therapy and topical diclofenac 3% in hyaluronan 2.5% gel.
    Gracia-Cazaña T; López MT; Oncins R; Gilaberte Y
    Dermatol Ther; 2015; 28(6):341-3. PubMed ID: 26291609
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
    Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
    Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of photodynamic therapy in Bowen's disease: an observational and descriptive study in 51 lesions.
    Truchuelo M; Fernández-Guarino M; Fleta B; Alcántara J; Jaén P
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):868-74. PubMed ID: 21740466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.